Breast Cancer in the 21st Century: Neu Opportunities and Neu Challenges-Reference-Cited by-同舟云学术

Breast Cancer in the 21st Century: Neu Opportunities and Neu Challenges

Published:2001-03 Issue:3 Volume:14 Page:213-218
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Mod Pathol

Author:

Schnitt Stuart J

Publisher

Springer Science and Business Media LLC

Subject

Pathology and Forensic Medicine

Link

http://www.nature.com/articles/3880288.pdf

Reference20 articles.

1. Perez E . Current management of metastatic breast cancer. Semin Oncol 1999; 26 (Suppl. 12): 1–10.

2. Hortobagyi GN, Hung M-C, Buzdar A . Recent developments in breast cancer therapy. Semin Oncol 1999; 26 (Suppl. 12): 11–20

3. Borden EC, Esserman L, Linder DJ, Campbell MJ, Fulton AM . Biological therapies for breast carcinoma: Concepts for improvement in survival. Semin Oncol 1999; 26 (Suppl. 12): 28–40.

4. DiGiovanna MP . Clinical significance of HER-2/neu overexpression: part I. PPO Updates 1999; 13 (9): 1–10.

5. DiGiovanna MP . Clinical significance of HER-2/neu overexpression: part II. PPO Updates 1999; 13 (10): 1–14.

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Value of CT-Based Radiomics in Predicating the Efficacy of Anti-HER2 Therapy for Patients With Liver Metastases From Breast Cancer;Frontiers in Oncology;2022-04-07

2. HER2-Low Breast Cancers;American Journal of Clinical Pathology;2021-09-14

3. Significance of HER2 in Microinvasive Breast Carcinoma;American Journal of Clinical Pathology;2021-01-25

4. Applying the New Guidelines of HER2 Testing in Breast Cancer;Current Oncology Reports;2020-04-29

5. A rapid triage protocol to optimize cold ischemic time for breast resection specimens;Annals of Diagnostic Pathology;2018-06